Answers are grounded in this paper and cite their sources.
Viewpoint discusses the rise and fall of safer supply programs for opioid users in Canada, highlighting critical lessons learned.
This Viewpoint discusses the implementation and subsequent deimplementation of safer supply programs in Canada, which provided access to pharmaceutical-grade medications for individuals who use unregulated substances, particularly opioids.
No takes yet. Share an insight, caveat, or question.
Karamouzian et al. (2026) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: